MRVI News and Press, Maravai LifeSciences Holdings Inc. From 08/07/23

SAN DIEGO, Aug. 07, 2023 (GLOBE NEWSWIRE) -- Maravai LifeSciences Holdings, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, today reported financial results for the second quarter ended June 30, 2023, together ...

2023-07-28 08:48:41 ET Life sciences company Maravai LifeSciences Holdings ( NASDAQ: MRVI ) said on Friday that William Martin has been appointed CEO, effective July 27. The appointment is consistent with the company's previously announced CEO succession plan. Interim...

William “Trey” Martin, III assumes the role of Maravai’s CEO Carl Hull to continue to serve as Executive Chairman SAN DIEGO, Calif., July 27, 2023 (GLOBE NEWSWIRE) -- Maravai LifeSciences Holdings, Inc. (“Maravai” or the “Company”...

SAN DIEGO, July 24, 2023 (GLOBE NEWSWIRE) -- Maravai LifeSciences Holdings, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, plans to announce its second quarter 2023 financial and operating results after the market ...

SAN DIEGO, July 20, 2023 (GLOBE NEWSWIRE) -- Maravai LifeSciences Holdings, Inc. (“Maravai” or the “Company”) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, announced that Robert (“Chip”)...

2023-07-14 11:30:36 ET Maravai LifeSciences ( NASDAQ: MRVI ) rose 3.4% amid a report that Germany's Merck KGaA ( OTCPK:MKGAF ) is speculated to be one of the companies looking at the vaccine reagent vendor. Merck ( OTCPK:MKGAF ) is rumored to have shown some int...

2023-06-16 10:45:50 ET Maravai LifeSciences ( NASDAQ: MRVI ) rose 2.2% amid a report of takeover interest from a strategic buyer for the vaccine reagent vendor. An unidentified strategic buyer is said to be competing with private equity firm Thomas H. Lee for Maravai ( M...

SAN DIEGO, June 06, 2023 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, recently hosted Congressman Scott Peters for a tour of the RNA manufacturing facility at Wateridge Circle in S...

2023-05-31 14:20:15 ET Maravai LifeSciences ( NASDAQ: MRVI ) rose 1.2% amid a report that private equity firm Thomas H. Lee bid $17 a share for the vaccine reagent vendor. Thomas H. Lee made the all-cash offer and is now conducting due diligence, according to a Street In...

GMP Facility Expected to Simplify the mRNA Drug Substance Development Process; Slated to Welcome Customers in Early 2024 TriLink BioTechnologies (TriLink ® ), a Maravai LifeSciences company (NASDAQ: MRVI) and global provider of life science reagents and services, ha...